Your browser doesn't support javascript.
loading
Development of independent dose verification plugin using Eclipse scripting API for brachytherapy.
Zhou, Dejun; Nakamura, Mitsuhiro; Sawada, Yohei; Ono, Tomohiro; Hirashima, Hideaki; Iramina, Hiraku; Adachi, Takanori; Fujimoto, Takahiro; Mizowaki, Takashi.
Affiliation
  • Zhou D; Department of Information Technology and Medical Engineering, Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Nakamura M; Department of Information Technology and Medical Engineering, Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Sawada Y; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Ono T; Division of Clinical Radiology Service, Kyoto University Hospital, Kyoto 606-8507, Japan.
  • Hirashima H; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Iramina H; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Adachi T; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Fujimoto T; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Mizowaki T; Division of Clinical Radiology Service, Kyoto University Hospital, Kyoto 606-8507, Japan.
J Radiat Res ; 64(1): 180-185, 2023 Jan 20.
Article in En | MEDLINE | ID: mdl-36214326
In this study, an independent dose verification plugin (DVP) using the Eclipse Scripting Application Programming Interface (ESAPI) for brachytherapy was developed. The DVP was based on the general 2D formalism reported in AAPM-TG43U1. The coordinate and orientation of each source position were extracted from the translation matrix acquired from the treatment planning system (TPS), and the distance between the source and verification point (r) was calculated. Moreover, the angles subtended by the center-tip and tip-tip of the hypothetical line source with respect to the verification point (θ and ß) were calculated. With r, θ, ß and the active length of the source acquired from the TPS, the geometry function was calculated. As the TPS calculated the radial dose function, g(r), and 2D anisotropy function, F(r,θ), by interpolating and extrapolating the corresponding table stored in the TPS, the DVP calculated g(r) and F(r,θ) independently from equations fitted with the Monte Carlo data. The relative deviation of the fitted g(r) and F(r,θ) for the GammaMed Plus HDR 192Ir source was 0.5% and 0.9%, respectively. The acceptance range of the relative dose difference was set to ±1.03% based on the relative deviation between the fitted functions and Monte Carlo data, and the linear error propagation law. For 64 verification points from sixteen plans, the mean of absolute values of the relative dose difference was 0.19%. The standard deviation (SD) of the relative dose difference was 0.17%. The DVP maximizes efficiency and minimizes human error for the brachytherapy plan check.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brachytherapy / Iridium Radioisotopes Limits: Humans Language: En Journal: J Radiat Res Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brachytherapy / Iridium Radioisotopes Limits: Humans Language: En Journal: J Radiat Res Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United kingdom